| Literature DB >> 24987426 |
Sogand Zareisedehizadeh1, Chay-Hoon Tan2, Hwee-Ling Koh1.
Abstract
Pereskia bleo, a leafy cactus, is a medicinal plant native to West and South America and distributed in tropical and subtropical areas. It is traditionally used as a dietary vegetable, barrier hedge, water purifier, and insect repellant and for maintaining health, detoxification, prevention of cancer, and/or treatment of cancer, hypertension, diabetes, stomach ache, muscle pain, and inflammatory diseases such as dermatitis and rheumatism. The aim of this paper was to provide an up-to-date and comprehensive review of the botanical characteristics, traditional usage, phytochemistry, pharmacological activities, and safety of P. bleo. A literature search using MEDLINE (via PubMed), Science direct, Scopus and Google scholar and China Academic Journals Full-Text Database (CNKI) and available eBooks and books in the National University of Singapore libraries in English and Chinese was conducted. The following keywords were used: Pereskia bleo, Pereskia panamensis, Pereskia corrugata, Rhodocacus corrugatus, Rhodocacus bleo, Cactus panamensis, Cactus bleo, Spinach cactus, wax rose, Perescia, and Chinese rose. This review revealed the association between the traditional usage of P. bleo and reported pharmacological properties in the literature. Further investigation on the pharmacological properties and phytoconstituents of P. bleo is warranted to further exploit its potentials as a source of novel therapeutic agents or lead compounds.Entities:
Year: 2014 PMID: 24987426 PMCID: PMC4060302 DOI: 10.1155/2014/326107
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Clades of the genus Pereskia [9].
| Clade A | Clade B |
|---|---|
|
|
|
Scientific and common names of P. bleo.
| Names | References |
|---|---|
| Scientific names | |
|
| [ |
|
| [ |
|
| [ |
|
| [ |
|
| [ |
|
| [ |
| Common names | |
| Butarrar (Kuna Indian) | [ |
| Cak Sing Cam, Qi xing zhen (Chinese) | [ |
| Chupa, Chupa melon, Najií, Najii De Culebra, Najú de esoubas, and Bleo de chupa (Spanish) | [ |
| Perescia | [ |
| Pokok Jarum Tujuh Bilah (Malay) | [ |
| Rose cactus, Bleo, Chinese rose, Spinach cactus, wax rose, and orange rose cactus (English) | [ |
Figure 1Photographs of different plant parts of P. bleo and P. grandifolia. (a) Flower of P. bleo, (b) lower of P. grandifolia [47], (c) stem and spines of P. bleo, (d) stem and spines of P. grandifolia [48], (e) ripe fruits and seeds of P. bleo, and (f) ripe fruits and seeds of P. grandifolia [49].
Traditional usage and methods of preparation of P. bleo.
| Purpose | Method of preparation | References |
|---|---|---|
| Detoxification and prevention of cancer | Making tea by boiling the leaves and/or the fruit and then drinking it warm or cool | [ |
|
| ||
| Dietary purposes and health maintenance | Eating the raw leaf, flower, and fruit | [ |
|
| ||
| Health maintenance and revitalizing the body | Making juice from the leaves and boiling in water and drinking every morning | [ |
|
| ||
| To alleviate muscleache | Making decoction from the leaves and then using as a warm bath for muscle ache | [ |
|
| ||
| To alleviate stomachache | Preparing “ina kuamakalet”: the inflorescence is mixed with the excrements of red ants by using a special mortar and then moistened with water. The resulted mass is moulded to oval shape objects which are dried in sun. When using the remedy, these balls are rubbed in a small container with a small amount of water. | [ |
|
| ||
| To treat hemorrhoid, hypertension, diabetes, infections, headache, and inflammatory conditions (rheumatism and asthma) | No information is available in the literature. | [ |
|
| ||
| To neutralize the effects of the snakebites | No information is available in the literature. | [ |
Reported phytoconstituents in the leaves and fruits of P. bleo.
| Plant part | Class of the constituents | Constituents | Reference |
|---|---|---|---|
| Leaves | Alkaloids | 3,4-Dimethoxy- | [ |
| 3-Methoxytyramine | [ | ||
| Tyramine | [ | ||
| Fatty acids | Methyl palmitate |
[ | |
| Methyl linoleate | |||
| Methyl | |||
| Flavonoid | Vitexin | [ | |
| Phytosterol glycoside |
| [ | |
| Lactone | Dihydroactinidiolide | [ | |
| Phenolic compounds | 2,4-Ditert-butylphenol | [ | |
|
| [ | ||
| Catechin | [ | ||
| Epicatechin | [ | ||
| Quercetin | [ | ||
| Myricetin | [ | ||
| Sterols | Campesterol | ||
| Stigmasterol | [ | ||
|
| [ | ||
| Terpenoids |
| [ | |
| Phytol | [ | ||
|
| |||
| Fruit | Carotenoids | Lutein ( | [ |
| Zeaxanthin ( | |||
Percentage (% w/w) of mineral contents in the leaves of P. bleo [38].
| Mineral elements | Percentage weight (%) |
|---|---|
| Carbon | 50.6 |
| Oxygen | 35.4 |
| Magnesium | 0.4 |
| Phosphorus | 0.4 |
| Sulfur | 1.5 |
| Chlorine | 1.2 |
| Potassium | 10.2 |
| Aluminium | ND* |
| Calcium | 0.3 |
| Silicon | ND |
| Ferrum (Iron) | ND |
*ND: not detected.
IC50 values (μg/mL) of P. bleo leaf extracts and fractions on different cell lines.
| Cell line | Extracts and fractions (IC50: | Positive control (IC50: | Negative control | References | ||||
|---|---|---|---|---|---|---|---|---|
| Methanol | Water | Hexane | Dichloromethane | Ethylacetate | ||||
| 4T1 | >50 | >50 | NA | NA | NA | Cisplatin (NA) | NA | [ |
| CasKi | 40.5 | — | 89.5 | NA | 58 | Doxorubicin (6 × 10−3) | NA | [ |
| CEM-ss | — | NA | — | — | — | NA | VC | [ |
| HT29 and HCT116 | >30 | NA | >30 | >30 | >30 | NA | VC | [ |
| 41.6 | — | 67.5 | NA | 22 | Doxorubicin (3.6 × 10−1) | NA | [ | |
| KB | 6.5 | — | 28 | NA | 4.5 | Doxorubicin (1.2 × 10−2) | NA | [ |
| MCF-7 | >30 | NA | >30 | >30 | >30 | NA | VC | [ |
| 39 | — | 25 | NA | 28 | Doxorubicin (7.5 × 10−2) | NA | [ | |
| MRC-5 | — | — | — | NA | — | Doxorubicin (5.5 × 10−1) | NA | [ |
| NIH/3T3 | ≥200 | ≥200 | NA | NA | NA | Cisplatin | NA | [ |
| Saos-2 | — | NA | NA | NA | NA | Cisplatin | NA | [ |
| T-47D | 2 | NA | NA | NA | NA | DNase I | VC | [ |
| V79 | — | NA | NA | NA | NA | Nitracrine | VC | [ |
IC50: 50% of maximum cell inhibition. IC50 < 20 μg/mL is considered active, 100 > IC50 > 20 μg/mL is relatively active, and IC50 > 100 is not active [8].
(—): no activity.
4T1: mouse mammary cancer cell line; CasKi: human cervical carcinoma cell line; CEM-ss: human T-4 lymphoblastoid cell line; HT29 and HCT116: human colon carcinoma cell line; KB: human nasopharyngeal epidermoid carcinoma cell line; MCF-7: hormone dependent breast carcinoma cell line; MRC-5: normal human fibroblast cell lines; NIH/3T3: normal mouse fibroblast cell line; Saos-2: human osteosarcoma cell line; T-47D: human breast carcinoma cell line; V79: Chinese hamster lung fibroblasts.
NA: not available.
VC: vehicle control.
Reported IC50 values (μg/mL) of selected P. bleo phytoconstituents on human cell lines [28].
| Compound | IC50 ( | |||||
|---|---|---|---|---|---|---|
| KB | MCF7 | CasKi | HCT 116 | A549 | MRC-5 | |
| Dihydroactinidiolide | 6.7 | 30 | 40 | 5 | 97 | 91.3 |
|
| >100 | 72 | 62 | >100 | 78 | >100 |
| 2,4-ditertbutylphenol | 0.81 | 5.75 | 4.5 | 29 | 6 | 20 |
|
| 8 | 7.5 | 6 | 31 | 6 | 30.5 |
| Phytol | 7.1 | 34 | 18 | 100 | 31 | 74.1 |
| Mixture of sterols | >100 | >100 | >100 | >100 | >100 | >100 |
| Doxorubicin | 1.3 × 10−2 | 7.6 × 10−2 | 6.0 × 10−3 | 3.6 × 10−1 | 2.2 × 10−1 | 5.5 × 10−1 |
A549: human lung carcinoma cell line, CasKi: human cervical carcinoma cell Line, HCT116: human colon carcinoma cell Line, KB: human nasopharyngeal epidermoid carcinoma cell Line, MCF-7: hormone dependent breast carcinoma cell Line, MRC-5: normal human fibroblast cell Lines.
Reported effects of P. bleo extracts on the growth of selected bacteria and fungi.
| Organism | Antibacterial and antifungal effect of the extracts | Positive control | References | |||||
|---|---|---|---|---|---|---|---|---|
| Methanol | Water | Hexane | Dichloroethane | Ethyl acetate | Chloroform | |||
|
| − | NA | − | − | − | NA | Streptomycin* | [ |
| − | − | − | NA | − | NA | Gentamicin, ampicillin | [ | |
| NA | NA | − | − | NA | NA | Streptomycin | [ | |
|
| − | NA | NA | − | NA | NA | Streptomycin | [ |
|
| − | − | − | NA | − | NA | Gentamicin, ampicillin | [ |
|
| − | NA | NA | − | NA | NA | Streptomycin | [ |
|
| − | NA | NA | − | NA | NA | Streptomycin | [ |
|
| − | NA | − | +++ | − | NA | Streptomycin* | [ |
| NA | NA | − | ++ | NA | NA | Streptomycin | [ | |
|
| − | NA | NA | − | NA | NA | Streptomycin | [ |
|
| ++ | NA | +++ | + | + | NA | Streptomycin | [ |
| + | − | − | NA | + | NA | Gentamicin, ampicillin | [ | |
| NA | NA | +++ | + | NA | NA | Streptomycin* | [ | |
|
| − | NA | NA | − | NA | NA | Streptomycin | [ |
|
| ++ | NA | +++ | − | − | NA | Streptomycin* | [ |
| NA | NA | +++ | − | NA | NA | Streptomycin | [ | |
|
| − | NA | NA | − | NA | NA | Streptomycin | [ |
|
| − | − | − | NA | − | NA | Gentamicin, ampicillin | [ |
|
| − | − | NA | NA | NA | − | Propiconazole, miconazole | [ |
|
| − | NA | NA | − | NA | NA | Amphotericin B | [ |
|
| + | + | NA | NA | NA | + | Propiconazole, miconazole | [ |
aThe screening for antibacterial effect was carried out by determining the zone of inhibition using paper disc, + stands for activity between 6–9 mm, ++ stands for activity between 9–14 mm, +++ stands for activity more than 14 mm [38].
b(+) stands for activity at 100 μg/mL for E. coli, S. aureus, K. pneumoniae, M. smegmatis, C. albicance, P. aeruginosa and at 12.5 μg/mL for H. pylori, (−) stands for inactive samples.
cagar overlay assay and (+) stands for active extracts at 50 μg/mL, (−) stands for inactive extract.
NA: not applicable as there is no report in the literature.
*Streptomycin showed 20 to 23 mm inhibition zone. The rest of the studies did not report the exact value of the inhibition for their positive controls.